{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:38:20Z","timestamp":1760384300877},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T00:00:00Z","timestamp":1092355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00213-004-1985-5","type":"journal-article","created":{"date-parts":[[2004,8,12]],"date-time":"2004-08-12T10:33:56Z","timestamp":1092306836000},"page":"67-77","source":"Crossref","is-referenced-by-count":23,"title":["Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats"],"prefix":"10.1007","volume":"178","author":[{"given":"Joseph H.","family":"Porter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Prus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Vann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Varvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,8,13]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","volume":"18","author":"J Arnt","year":"1998","unstructured":"Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63?101","journal-title":"Neuropsychopharmacology"},{"key":"CR2","first-page":"576","volume":"260","author":"C Bolden","year":"1992","unstructured":"Bolden C, Cusack B, Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260:576?580","journal-title":"J Pharmacol Exp Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","volume":"14","author":"FP Bymaster","year":"1996","unstructured":"Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87?96","journal-title":"Neuropsychopharmacology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.pnpbp.2003.09.008","volume":"27","author":"FP Bymaster","year":"2003","unstructured":"Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, McKinzie DL (2003) Muscarinic mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27:1125?1143","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s002130050344","volume":"132","author":"GJ Carey","year":"1997","unstructured":"Carey GJ, Bergman J (1997) Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology 132:261?269","journal-title":"Psychopharmacology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0028-3908(03)00040-6","volume":"44","author":"A Dekeyne","year":"2003","unstructured":"Dekeyne A, Iob L, Millan MJ (2003) Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907. Neuropharmacology 44:604?615","journal-title":"Neuropharmacology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00426467","volume":"73","author":"K Extance","year":"1981","unstructured":"Extance K, Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73:363?371","journal-title":"Psychopharmacology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0028-3908(95)00101-B","volume":"34","author":"D Fiorella","year":"1995","unstructured":"Fiorella D, Helsley S, Rabin RA, Winter JC (1995) The interactions of typical and atypical antipsychotics with the (?)2, 5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus. Neuropharmacology 34:1297?1303","journal-title":"Neuropharmacology"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(84)90695-2","volume":"106","author":"RL Friedman","year":"1985","unstructured":"Friedman RL, Sanders-Bush E, Barrett RL (1985) Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol 106:191?193","journal-title":"Eur J Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0091-3057(94)90480-4","volume":"49","author":"DV Gauvin","year":"1994","unstructured":"Gauvin DV, Goulden KL, Holloway FA (1994) A three-choice haloperidol?saline?cocaine drug discrimination task in rats. Pharmacol Biochem Behav 49:223?227","journal-title":"Pharmacol Biochem Behav"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(78)90310-6","volume":"8","author":"JA Goas","year":"1978","unstructured":"Goas JA, Boston JE Jr (1978) Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8:235?241","journal-title":"Pharmacol Biochem Behav"},{"key":"CR12","volume-title":"Biostatistics: an introductory text","author":"A Goldstein","year":"1964","unstructured":"Goldstein A (1964) Biostatistics: an introductory text. MacMillan, New York"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/1064-1297.8.3.415","volume":"8","author":"AK Goodwin","year":"2000","unstructured":"Goodwin AK, Baker LE (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (\ufffd)-MDMA in rats. Exp Clin Psychopharmacol 8:415?423","journal-title":"Exp Clin Psychopharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-3057(99)00079-9","volume":"64","author":"AJ Goudie","year":"1999","unstructured":"Goudie AJ, Smith JA (1999) Discriminative stimulus properties of antipsychotics. Pharmacol Biochem Behav 64:193?201","journal-title":"Pharmacol Biochem Behav"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002130050527","volume":"135","author":"A Goudie","year":"1998","unstructured":"Goudie A, Taylor A (1998) Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392?400","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00008877-199812000-00006","volume":"9","author":"AJ Goudie","year":"1998","unstructured":"Goudie AJ, Smith JA, Taylor A, Taylor MA, Tricklebank MD (1998) Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands. Behav Pharmacol 9:699?710","journal-title":"Behav Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00008877-200109000-00001","volume":"12","author":"AJ Goudie","year":"2001","unstructured":"Goudie AJ, Baker LE, Smith JA, Prus AJ, Svensson KA, Cortes-Burgos LA, Wong EH, Haadsma-Svensson S (2001) Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms. Behav Pharmacol 12:303?315","journal-title":"Behav Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00213-003-1576-x","volume":"171","author":"AJ Goudie","year":"2004","unstructured":"Goudie AJ, Smith JA, Millan MJ (2004) Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine. Psychopharmacology 171:212?222","journal-title":"Psychopharmacology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0006-3223(93)90043-D","volume":"34","author":"C Hagger","year":"1993","unstructured":"Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY (1993) Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 34:702?712","journal-title":"Biol Psychiatry"},{"key":"CR20","first-page":"276","volume":"263","author":"EM Hoenicke","year":"1992","unstructured":"Hoenicke EM, Vanecek SA, Woods JH (1992) The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. J Pharmacol Exp Ther 263:276?284","journal-title":"J Pharmacol Exp Ther"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789?796","journal-title":"Arch Gen Psychiatry"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","volume":"27","author":"S Kapur","year":"2003","unstructured":"Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27:1081?1090","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0091-3057(96)00342-5","volume":"57","author":"BM Kelley","year":"1997","unstructured":"Kelley BM, Porter JH (1997) The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats. Pharmacol Biochem Behav 57:707?719","journal-title":"Pharmacol Biochem Behav"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s002130050919","volume":"143","author":"EA Mariathasan","year":"1999","unstructured":"Mariathasan EA, Stolerman IP, White J-AW (1999) AND and AND?OR drug mixture discriminations in rats: generalization to single drugs and drug mixtures. Psychopharmacology 143:54?63","journal-title":"Psychopharmacology"},{"key":"CR25","first-page":"687","volume":"16","author":"R Matz","year":"1974","unstructured":"Matz R, Rick W, Thompson H, Gershon S (1974) Clozapine?a potential antipsychotic agent without extrapyramidal manifestations. Curr Ther Res Clin Exp 16:687?695","journal-title":"Curr Ther Res Clin Exp"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ddr.430180106","volume":"18","author":"JF McElroy","year":"1989","unstructured":"McElroy JF, Stimmel JJ, O?Donnell JM (1989) Discriminative stimulus properties of haloperidol. Drug Dev Res 18:47?55","journal-title":"Drug Dev Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-003-1529-4","volume":"170","author":"KI Melkersson","year":"2003","unstructured":"Melkersson KI, Dahl M-L (2003) Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses. Psychopharmacology 170:157?166","journal-title":"Psychopharmacology"},{"key":"CR28","first-page":"1","volume-title":"Novel antipsychotic drugs","author":"HY Meltzer","year":"1992","unstructured":"Meltzer HY (1992) The mechanism of action of clozapine in relation to its clinical advantages. In: Meltzer HY (ed) Novel antipsychotic drugs. Raven, New York, pp 1?13"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","volume":"25","author":"HY Meltzer","year":"1999","unstructured":"Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233?255","journal-title":"Schizophr Bull"},{"key":"CR30","first-page":"238","volume":"251","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238?246","journal-title":"J Pharmacol Exp Ther"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","volume":"60","author":"HY Meltzer","year":"2003","unstructured":"Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S (2003a) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60:82?91","journal-title":"Arch Gen Psychiatry"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","volume":"27","author":"HY Meltzer","year":"2003","unstructured":"Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003b) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:1159?1172","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR33","first-page":"1356","volume":"286","author":"MJ Millan","year":"1999","unstructured":"Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, Sebban C, Maurel-Remy S, Newman-Tancredi A, Spedding M, Muller O, LaVielle G, Brocco M (1999) S 16924 ((R)-2-{1-[2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl}-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties. II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther 286:1356?1373","journal-title":"J Pharmacol Exp Ther"},{"key":"CR34","first-page":"545","volume":"262","author":"NA Moore","year":"1992","unstructured":"Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel ?atypical? antipsychotic agent. J Pharmacol Exp Ther 262:545?551","journal-title":"J Pharmacol Exp Ther"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00735891","volume":"94","author":"EB Nielsen","year":"1988","unstructured":"Nielsen EB (1988) Cholinergic mediation of the discriminative stimulus properties of clozapine. Psychopharmacology 94:115?118","journal-title":"Psychopharmacology"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0091-3057(94)90464-2","volume":"49","author":"PA Palumbo","year":"1994","unstructured":"Palumbo PA, Winter JC (1994) Interactions of clozapine with the stimulus effects of DOM and LSD. Pharmacol Biochem Behav 49:115?120","journal-title":"Pharmacol Biochem Behav"},{"key":"CR37","series-title":"Program number 858.8. 2003 Abstract Viewer\/Itinerary Planner","volume-title":"Two-lever drug discrimination with the typical antipsychotic clozapine in C57BL\/6 mice","author":"SD Philibin","year":"2003","unstructured":"Philibin SD, Pehrson AL, Prus AJ, Porter JH (2003) Two-lever drug discrimination with the typical antipsychotic clozapine in C57BL\/6 mice. Program number 858.8. 2003 Abstract Viewer\/Itinerary Planner. Society for Neuroscience, Washington"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002130050127","volume":"128","author":"JH Porter","year":"1996","unstructured":"Porter JH, Strong SE (1996) Discriminative stimulus control with olanzapine: generalization to the atypical antipsychotic clozapine. Psychopharmacology 128:216?219","journal-title":"Psychopharmacology"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1098-2299(199909)48:1<38::AID-DDR5>3.0.CO;2-C","volume":"48","author":"JH Porter","year":"1998","unstructured":"Porter JH, Covington HE, Varvel SA, Vann RE, Warren TA (1998) Chlorpromazine as a discriminative stimulus in rats: generalization to typical and atypical antipsychotics. Drug Dev Res 48:38?44","journal-title":"Drug Dev Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1098-2299(199902)46:2<139::AID-DDR7>3.0.CO;2-S","volume":"46","author":"JH Porter","year":"1999","unstructured":"Porter JH, Villanueva HF, Rosecrans JA (1999) Role of D1 and D2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats. Drug Dev Res 46:139?147","journal-title":"Drug Dev Res"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s002130050046","volume":"148","author":"JH Porter","year":"2000","unstructured":"Porter JH, McCallum SE, Varvel SA, Vann RE (2000a) The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats. Psychopharmacology 148:224?233","journal-title":"Psychopharmacology"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002139900366","volume":"149","author":"JH Porter","year":"2000","unstructured":"Porter JH, Varvel SA, Vann RE, Philibin SD, Wise LE (2000b) Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology 149:189?193","journal-title":"Psychopharmacology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2003.10.010","volume":"77","author":"AJ Prus","year":"2004","unstructured":"Prus AJ, Baker LE, Meltzer HY (2004) Discriminative stimulus properties of 1.25\ufffdmg\/kg and 5.0\ufffdmg\/kg doses of clozapine in rats: further examination of the role of dopamine, serotonin and muscarinic receptor mechanisms. Pharmacol Biochem Behav 77:199?208","journal-title":"Pharmacol Biochem Behav"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","volume":"68","author":"E Richelson","year":"2000","unstructured":"Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors: focus on newer generation compounds. Life Sci 68:29?39","journal-title":"Life Sci"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","volume":"124","author":"A Schotte","year":"1996","unstructured":"Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57?73","journal-title":"Psychopharmacology"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(94)90643-2","volume":"264","author":"R Schreiber","year":"1994","unstructured":"Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ?atypical? antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99?102","journal-title":"Eur J Pharmacol"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1037\/1064-1297.10.4.376","volume":"10","author":"JA Smith","year":"2002","unstructured":"Smith JA, Goudie AJ (2002) Discriminative stimulus properties in rats of the novel antipsychotic quetiapine. Exp Clin Psychopharmacol 10:376?384","journal-title":"Exp Clin Psychopharmacol"},{"issue":"Suppl","key":"CR48","first-page":"18","volume":"5","author":"IP Stolerman","year":"1994","unstructured":"Stolerman IP, Mariathasan EA, White J-AW (1994) Implications of mixture research for discrimination of single drugs. Behav Pharmacol 5(Suppl):18","journal-title":"Behav Pharmacol"},{"key":"CR49","series-title":"NIDA Research monograph 162","first-page":"214","volume-title":"Problems of drug dependence 1995","author":"IP Stolerman","year":"1996","unstructured":"Stolerman IP, White J-AW, Mariathasan EA (1996) Generalizations between mixtures of drugs under ?AND? and ?AND?OR? discrimination procedures in rats. In: Harris LS (ed) Problems of drug dependence 1995. NIDA Research monograph 162. US Government Printing Office, Washington, p 214"},{"key":"CR50","first-page":"440","volume":"281","author":"AH Tang","year":"1997","unstructured":"Tang AH, Franklin SR, Himes CS, Smith MW, Tenbrink RE (1997) PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J Pharmacol Exp Ther 281:440?447","journal-title":"J Pharmacol Exp Ther"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s002130100714","volume":"155","author":"EA Walker","year":"2001","unstructured":"Walker EA, Picker MJ, Dykstra LA (2001) Three-choice discrimination in pigeons is based on relative efficacy differences among opioids. Psychopharmacology 155:389?396","journal-title":"Psychopharmacology"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427484","volume":"80","author":"JM White","year":"1983","unstructured":"White JM, Holtzman SG (1983) Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids. Psychopharmacology 80:1?9","journal-title":"Psychopharmacology"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0091-3057(92)90433-G","volume":"43","author":"JL Wiley","year":"1992","unstructured":"Wiley JL, Porter JH (1992) Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43:961?965","journal-title":"Pharmacol Biochem Behav"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1037\/1064-1297.5.3.216","volume":"5","author":"CR Young","year":"1997","unstructured":"Young CR, Longhurst JG, Bowers MB Jr, Mazure CM (1997) The expanding indications for clozapine. Exp Clin Psychopharmacol 5:216?234","journal-title":"Exp Clin Psychopharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-1985-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1985-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:01:20Z","timestamp":1558641680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-1985-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,13]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-1985-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,13]]}}}